FrançaisAre analysts right about Scotts Miracle-Gro Company (SMG)?
📈 See the interactive version (live chart) →
Historical analyst accuracy
For Scotts Miracle-Gro Company, we replayed every analyst price target of the past 12 months and measured the real outcome: 16% were profitable, average return -13% (85 calls). At 3 months: -3% average return (32% profitable). The higher the %, the more often analysts were right on this stock.
Most reliable analysts on this stock (past track record)
Their past track record on this stock (targets replayed against real prices) — not a forecast of what will happen.
| Analyst / broker | Calls i | % profitable i | Avg return i |
|---|---|---|---|
| Raymond James | 21 | 19% | -16% |
| Wells Fargo | 17 | 12% | -16% |
| B of A Securities | 10 | 10% | -15% |
| JP Morgan | 10 | 10% | -13% |
| Truist Securities | 8 | 12% | -20% |
Valuation
Is Scotts Miracle-Gro Company overvalued, and is it a good time to buy Scotts Miracle-Gro Company right now? If you're wondering, here's a recap to make up your own mind: Scotts Miracle-Gro Company's valuation vs its sector median, to weigh alongside analyst reliability (above) and past performance. Educational information, not buy advice.
The P/E (price ÷ earnings per share) = how many years of earnings you pay for the stock. The higher it is, the more growth the market expects — but the pricier the stock, so more vulnerable if growth disappoints. The forward P/E uses next year's expected earnings: lower than the current P/E = rising expected earnings. We compare it to the sector median to see whether the stock is expensive relative to its peers.
| Metric | Scotts Miracle-Gro Company | Sector median (Materials) |
|---|---|---|
| P/E | 23.4 | 23.4 |
| Forward P/E | 12.8 | 15.9 |
| Net margin | 2% | 8% |
👉 Scotts Miracle-Gro Company is valued in line with its sector (23.4 vs 23.4).
📖 P/E, PEG, margin…: see the glossary
💵 Dividend : Scotts Miracle-Gro Company pays about $2.64/share/yr → 3.85% yield. what is this?
Frequently asked questions
Is Scotts Miracle-Gro Company a buy right now?
The analyst consensus on Scotts Miracle-Gro Company (SMG) is "Buy" (10 bullish, 0 bearish calls over 12 months). This is not advice: historically, 16% of their targets on this stock turned out profitable over 1 year.
What is Scotts Miracle-Gro Company's price target?
The median 12-month price target is $76.50 (+26% vs $60.59), ranging from $67.00 to $78.00 (4 analysts).
Are analysts accurate on Scotts Miracle-Gro Company?
Over 1 year, 16% of analyst targets on Scotts Miracle-Gro Company were profitable, for an average return of -13% (across 85 timestamped calls). This is JPI Invest's accuracy metric.
What is the Scotts Miracle-Gro Company stock forecast?
Analysts target a median of $76.50 within 12 months, i.e. +26% vs the current price. The most bullish targets $78.00, the most cautious $67.00.
What is the Scotts Miracle-Gro Company stock forecast for 2026 or long term (2030)?
Note: analyst targets are 12-month (median $76.50, +26%), NOT 2030. No reliable 5-10 year price forecast exists (« 2030 prediction » models are speculative). The most useful inputs: the 12-month median above, these analysts' historical accuracy (16%), and the stock's past trajectory.
Is Scotts Miracle-Gro Company overvalued?
Its P/E is 23.4, forward P/E 12.8. A forward P/E lower than the current P/E means earnings are expected to grow.
📊 See the full interactive analysis of Scotts Miracle-Gro Company →
What is JPI Invest?
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
- 🏆 Analyst leaderboard by real reliability (beating their sector, not just riding the rally)
- 🎯 What to buy: 3 backtested methods over 6 years, from cautious to aggressive
- 💬 AI assistant: ask anything about any stock, with the numbers
- 📊 Portfolio tracking + 🔔 price alerts by email
⚠️ Educational information, not investment advice. Analyst price targets are 12-month and can be wrong. Data via Yahoo Finance, recomputed by JPI Invest.